Medical devices, healthcare technology and the business of care
510(k) clearance · K252584

Insufflator (wAlcor C50A, wAlcor C50B, wAlcor C50C, wAlcor C35A, wAlcor C35B, wAlcor C35C)

Weyo Surgical Technology , Ltd. · Decision date Jun 25, 2026

FDA DECISIONK252584

What did the FDA decide?

FDA records K252584 as a 510(k) premarket notification, with a decision dated Jun 25, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Obstetrics/Gynecology
Decision date
Jun 25, 2026

FDA source record

Regulatory record facts

Identifier
K252584
Regulatory pathway
510(k) premarket notification
Product code
HIF
Decision code
SESE
Decision date
Jun 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Insufflator, Laparoscopic.

Product code
HIF
FDA device class
2

FDA decision timeline

  1. K252584 received

    Application receipt date recorded by FDA.

  2. K252584 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HIF

Product / regulatory recordCompanyPathwayDecision dateSource
Karl Storz SE & CO. KG510(k) clearanceAug 19, 2026FDA
Guangdong Optomedic Technologies, Inc.510(k) clearanceApr 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Weyo Surgical Technology , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Nanjing

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records